Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Contributed by: Business Wire

Logo

Tags

Biotechnology

FDA

Other Health

Health

General Health

Pharmaceutical

Mental Health

Other Science

Research

Science

Clinical Trials

Compass Pathfinder Limited

More Like This

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants

Compass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026